Market Research Assistance

On the Web
Refine Result

By Date

Last Month
Last 3 Months
Last 6 Months
Last Year
Last 2 Years

By Price

< $1000
$1000-$2500
$2501-$4000
$4001-$5500
$5501-$7500
$7501-$9000
>$9000

Arthritis therapeutics Market Research Reports

Titlepublishedprice

Systemic Idiopathic Juvenile Arthritis - Pipeline Review, H1 2017

By Global Markets Direct
"...... hic Juvenile Arthritis (Musculoskeletal Disorders) pipeline landscape. Systemic onset juvenile idiopathic arthritis (also known as Systemic juvenile idiopathic arthritis (sJIA)) is a disorder featuring inflammation, characterized by high......"
31-Mar-2017$2000

Global Arthritis Partnering 2010 to 2017

By Current Partnering
"...... ments since 2010 report provides understanding and access to partnering deals and agreements entered into by the world's leading healthcare companies. - Trends in partnering deals - Top deals by value - Deals listed by co......"
01-Mar-2017$1495

Global Rheumatoid Arthritis Partnering 2010 to 2017

By Current Partnering
"...... ms and Agreements since 2010 report provides understanding and access to partnering deals and agreements entered into by the world's leading healthcare companies. - Trends in partnering deals - Top deals by value - Deals ......"
01-Mar-2017$1495

Global Osteoarthritis Partnering 2010 to 2017

By Current Partnering
"...... and Agreements since 2010 report provides understanding and access to partnering deals and agreements entered into by the world's leading healthcare companies. - Trends in partnering deals - Top deals by value - Deals li......"
01-Mar-2017$1495

Juvenile Arthritis-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2017

By Delve Insight
"...... Report is to understand the market and pipeline status of the drugs around the Juvenile Arthritis to explore the generic development opportunities, licensing opportunities and to gain competitive advantage on designing pipeline startegies. The DelveI......"
01-Jan-2017$2000

Gouty Arthritis (Gout)-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2017

By Delve Insight
"...... (Gout) Report is to understand the market and pipeline status of the drugs around the Gouty Arthritis (Gout) to explore the generic development opportunities, licensing opportunities and to gain competitive advantage on designing pipeline startegies......"
01-Jan-2017$2000

Juvenile Rheumatoid Arthritis-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2017

By Delve Insight
"...... Rheumatoid Arthritis Report is to understand the market and pipeline status of the drugs around the Juvenile Rheumatoid Arthritis to explore the generic development opportunities, licensing opportunities and to gain competitive advantage on designin......"
01-Jan-2017$2000

Joint Pain-Pipeline Insights, 2017

By Delve Insight
"...... I, Phase II, Phase III and Preregistration. Report covers the product clinical trials information and other development activities including technology, licensing, collaborations, acquisitions, fundings, patent and USFDA & EMA designations details. D......"
01-Jan-2017$1250

EpiCast Report: Systemic Lupus Erythematosus (SLE) - Epidemiology Forecast to 2025

By GlobalData
"...... anifestations ranging from dermatological involvement to multi-organ failure with episodes of relapses and remissions. Because of its dynamic nature, this disease has an unpredictable natural course leading to high rates of morbidity and even death. ......"
01-Jan-2017$3995

Juvenile Rheumatoid Arthritis-Pipeline Insights, 2017

By Delve Insight
"...... g Discovery, Pre-clinical, IND, Phase I, Phase II, Phase III and Preregistration. Report covers the product clinical trials information and other development activities including technology, licensing, collaborations, acquisitions, fundings, patent a......"
01-Jan-2017$1250